Lbp Am Sa Buys 3,116 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

LBP AM SA boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 6.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 49,913 shares of the medical device company's stock after purchasing an additional 3,116 shares during the quarter. LBP AM SA's holdings in Cooper Companies were worth $4,589,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Ashton Thomas Securities LLC bought a new stake in Cooper Companies during the third quarter worth $25,000. Byrne Asset Management LLC bought a new position in shares of Cooper Companies in the fourth quarter valued at approximately $33,000. OFI Invest Asset Management bought a new stake in shares of Cooper Companies during the 4th quarter valued at about $34,000. Covestor Ltd lifted its holdings in shares of Cooper Companies by 144.9% during the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company's stock worth $37,000 after acquiring an additional 200 shares during the last quarter. Finally, Brown Brothers Harriman & Co. lifted its stake in Cooper Companies by 191.0% during the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company's stock worth $46,000 after purchasing an additional 275 shares during the last quarter. 24.39% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of analysts recently weighed in on the company. Citigroup dropped their target price on Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Piper Sandler restated an "overweight" rating and issued a $115.00 price objective (down from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. StockNews.com downgraded shares of Cooper Companies from a "buy" rating to a "hold" rating in a research note on Wednesday, December 11th. JPMorgan Chase & Co. lowered their price target on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research note on Friday, March 7th. Finally, Morgan Stanley decreased their price target on shares of Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a research note on Friday, December 6th. Three equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $111.89.

Remove Ads

Cooper Companies Stock Down 0.8 %

COO stock traded down $0.66 on Monday, reaching $80.56. 1,411,843 shares of the company traded hands, compared to its average volume of 1,256,121. The Cooper Companies, Inc. has a one year low of $77.05 and a one year high of $112.38. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company has a market cap of $16.11 billion, a P/E ratio of 41.33, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The firm has a fifty day simple moving average of $91.20 and a 200-day simple moving average of $98.93.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting the consensus estimate of $0.92. The firm had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Research analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.